{
  "figure_1": "Patient disposition MTD Maximum tolerated dose, PDy pharmacodynamics, PK pharmacokinetics",
  "figure_2": "Mean plasma concentration–time curves of milademetan A Day 1 of cycle 1; B day 14 of cycle 1. Cohort 1, 90 mg 14/28 once daily; cohort 2, 120 mg 14/28 once daily; and cohort 3, 160 mg 14/28 once daily. Data represent the arithmetic mean ± standard deviation",
  "figure_3": "Mean macrophage inhibitory cytokine-1 (MIC-1) serum level C cycle, D day, MIC-1 macrophage inhibitory cytokine-1"
}